Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Decitabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 24 Myelodysplastic Syndromes 13 Leukemia, Myelomonocytic, Chronic 7 Leukemia 5 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Monocytic, Acute 2 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Solid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms 1 Myeloid Malignancies 1 Lymphodepleting Chemotherapy 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Anemia, Refractory 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Anastrozole 2 ribociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Neoadjuvant Therapy 1 Immunoenzyme Techniques 1 Everolimus 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡